Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice
Webinar presenters Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
August 2016—SeraCare Life Sciences and the U.S. Department of Commerce National Institute of Standards and Technology have signed a three-year cooperative research and development agreement (CRADA) to advance the development of circulating tumor DNA diagnostic assay reference standard materials.
August 2016—GenMark Diagnostics received the CE mark for its ePlex Instrument System and ePlex Respiratory Pathogen (RP) Panel. The panel detects 20 viral and three bacterial targets in nasopharyngeal specimens.
August 2016—Qiagen has entered into a licensing and co-development agreement with Munich-based Therawis Diagnostics to develop and commercialize predictive assays in oncology. An initial project will be to develop and market PITX2 as a marker to predict the effectiveness of anthracycline treatment in triple-negative and other high-risk breast cancer patients.
August 2016—The Tissue-Tek Cryo3 Flex Cryostat, from Sakura Finetek USA, produces sections from 1 to 99 µm using a temperature-controlled blade holder and a 3-D precision chuck to accurately align the block face to the blade, reducing user’s trimming time and preserving specimens.
July 2016—SciGene introduced its MicroFISH Assay System, a clinically validated method combining microvolume, multiwell slides with SciGene slide processing instruments to perform routine cellular fluorescence in situ hybridization in cytogenetic laboratories.
July 2016—Invitrogen SuperScript IV VILO Master Mix from Thermo Fisher Scientific is a cDNA reaction master mix designed for two-step quantitative PCR (RT-qPCR) applications. The master mix format uses variable input, linear output technology and combines optimized buffer conditions with Invitrogen SuperScript IV reverse transcriptase.
Under terms of an agreement with Illumina, ArcherDx will lead the development of a series of diagnostic tests, using ArcherDx’s Anchored Multiplex PCR chemistry, that will run on the Illumina MiSeqDx instrument.
July 2016—Genomics plc, a company that develops algorithms and software solutions to uncover the relationships between genetic variation and human disease, has entered into a research collaboration with DNAnexus, a cloud-based genome informatics and data management platform.
July 2016—Bio-Rad Laboratories released its Liquichek Maternal Serum II Control, a frozen liquid human serum-based material designed to monitor the precision of laboratory test procedures used during maternal serum second trimester screening.
July 2016—Bioo Scientific has launched the Nextflex BRCA1 and BRCA2 Amplicon Panel for FFPE Illumina-compatible sequencing. The panel detects clinically relevant somatic mutations in DNA isolated from formalin-fixed, paraffin-embedded samples to facilitate variant discovery and confirmation.
